Ligand Advances Strategic Growth with Expanded and Strengthened Business Development Team
Go back to Ligand Advances Strategic Growth with Expanded and Strengthened Business Development Team| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 288.11 -2.6 (0.89%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $290.71 | 52 Week High | $139.79 | |||
| Open | $289.11 | 52 Week Low | $82.07 | |||
| Day High | $293.37 | P/E | 670.02 | |||
| Day Low | $284.87 | EPS | $0.43 | |||
| Volume | 83,559 | |||||

